New state-of-the-art technology helps clinicians provide personalised pain relief Ramat Gan, Israel, 18 January 2017 — Medasense Biometrics Ltd. announced today that it has received CE mark approval for its…
Medasense Biometrics Ltd. Raises $8 Million Investment in Series B Financing Accelerating the Commercialization of Objective Pain Monitoring Medasense Biometrics Ltd., developer of a proprietary objective pain monitoring technology, announced…
May 2016 – ASA’s Press Release About Dr. Ruth Edry and Prof. Daniel Sessler’s study The American Society of Anesthesiologists (ASA) publicized Medasense’s latest study, led by Dr. Ruth Edry…
Baxter Ventures joins Medasense Biometrics Ltd. Series B Financing Funding to accelerate global clinical research and market development for the NoL™ pain monitoring technology Ramat Gan, May 23, 2016 –…
